NYSE:LSPD News 3 November 2025

Anthropic’s Record-Breaking Rise: $13B Mega-Funding, Big Tech Deals & the AI Showdown in 2025

Anthropic Developments and News as of November 3, 2025 In summary, Anthropic in late 2025 stands as a centerpiece of the global AI drama – a startup-turned-goliath with extraordinary funding, big-tech allies, and cutting-edge AI models, all vying to shape the future of AI. Its recent moves – from mega-financing and TPU mega-clusters to enterprise-friendly AI tools – illustrate both the immense potential and the grand challenges of the AI revolution. As Anthropic races OpenAI, Google DeepMind, xAI and others, the world will be watching to see if this safety-focused upstart can lead in innovation without losing its soul to

3 November 2025

Artificial Intelligence·NASDAQ:AMZN·NASDAQ:GOOG·NASDAQ:GOOGL·NYSE:LSPD

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

7 February 2026

Nvidia shares jumped 7.9% to $185.41 Friday, their strongest gain in weeks, as chip stocks rallied on news of major AI infrastructure spending by Amazon and Alphabet. The PHLX semiconductor index rose 5.7%. Investors now await U.S. inflation data on Feb. 13 and Nvidia’s earnings report on Feb. 25.

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026

Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026

Pfizer shares rose 2.8% to $27.22 Friday after the FDA granted priority review for a Hympavzi label expansion, with a decision expected in Q2 2026. Trading volume reached 50.7 million shares. The TrumpRx.gov drug-discount rollout put renewed focus on pricing, with over 30 Pfizer drugs listed at launch.

Bitfarms stock jumps on Keel rebrand and U.S. redomiciliation plan — what BITF investors watch next

7 February 2026

Bitfarms shares jumped 25.2% to $2.14 Friday after the company announced plans to move its legal home to the U.S. and rebrand as Keel Infrastructure, pending a March 20 shareholder vote. The company also said it will repay its $100 million Macquarie debt facility and reported $698 million in net liquidity.

NYSE:LSPD News 3 November 2025

Anthropic’s Record-Breaking Rise: $13B Mega-Funding, Big Tech Deals & the AI Showdown in 2025

Stock Market Today

Nvidia stock price rebounds nearly 8% as AI spending race heats up — what to watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

Bitfarms stock jumps on Keel rebrand and U.S. redomiciliation plan — what BITF investors watch next